Ibudilast inhibits chemokine expression in rheumatoid synovial fibroblasts and exhibits immunomodulatory activity in experimental arthritis
<br/><strong>Objective: </strong>Ibudilast is a well‐tolerated, orally available type 4 phosphodiesterase (PDE4) inhibitor used to treat asthma and stroke. As PDE4 inhibition suppresses inflammatory mediator production and cell proliferation in leukocytes, ibudilast may be a valuab...
| Autori principali: | , |
|---|---|
| Natura: | Journal article |
| Pubblicazione: |
Wiley
2018
|